The Weber Light Letter

From studies to practice: The latest in tPBM and laser therapy for clinicians.

Photobiomodulation | Research | Clinical Practice

Subscribe: The Weber Light Letter

Proudly Introducing The Light Medicine Podcast

One of the most important parts of medicine is conversation. Between patients and doctors, between science and application, and increasingly, between innovators who share a vision for what healing can become.

That’s why I launched The Light Medicine Podcast.

Over the last 25 years, I’ve had the privilege to work at the intersection of laser technology, clinical research, and global health. These conversations with physicians, researchers, and pioneers, have shaped everything we build at Weber Medical. Now, we’re opening that dialogue to you.

In our first episode, I sat down with Dr. Matthias Wojcik, a pharmacist and longevity-focused entrepreneur, to explore:

• How light influences mitochondrial and immune function
• The practical differences between laser and LED-based systems
• Protocols for addressing chronic fatigue, brain fog, and neuroinflammation

 

It’s a deep and grounded conversation, built on science, not speculation.

📺 Watch or Listen: → YouTube → Spotify → Apple Podcasts

---

Why 3 Wavelengths Matter: Depth, Precision, and Protocol

The Weber Brain Device uses three laser wavelengths — each selected for its ability to reach a specific layer of brain tissue.

• 680 nm (Red Light): Stimulates surface mitochondria, enhances skin-brain interface metabolism
• 808 nm (Near-Infrared): Improves blood flow, oxygen delivery, and vascular tone
• 1064 nm (Infrared): Penetrates deep into cortical and subcortical regions, including areas tied to memory, sleep, and cognition

 

Each wavelength works synergistically to engage different biological systems that contribute to recovery and resilience.

---

Protocol Highlight: tPBM for Post-COVID Cognitive Fog

In a 2024 double-blind, placebo-controlled trial, researchers applied a transcranial PBM protocol (808 nm, 20-minute sessions, 3x/week for 6 weeks) to patients recovering from COVID-19-related brain fog and fatigue.

Results showed:

• 📈 Working memory improved by 27%
• 😴 Sleep latency decreased (patients fell asleep faster and stayed asleep longer)
• 🧘 Reduction in reported anxiety and mental fatigue

 

While the Weber Brain Device was not used in this trial, the protocol mirrors our current clinical configuration, reinforcing its role in supporting recovery from viral and inflammatory damage.

📑 Reference: NeuroRegeneration Journal, 2024

---

Update: Shipping Begins for the First 80 WeberBrain Pro Systems

Within the next 3–5 weeks, we’ll begin delivery of the first units of the WeberBrain Pro, our most advanced system for transcranial photobiomodulation (tPBM) in clinical settings.

Each system includes:

✅ 680 medical-grade lasers

✅ 3 therapeutic wavelengths for tissue depth targeting

✅ Full-brain coverage, with the ability to focus on specific lobes or regions

✅ Maximum protocol flexibility, designed for clinical integration and specialist use

If you’ve already reserved a system, you’ll receive direct shipment updates shortly.

We’re now opening Wave 2 of pre-orders for clinicians and researchers.

📩 DM me to add your name to the waitlist

---

Upcoming Event

A4M World Congress December 12–14, 2025 | Las Vegas, NV I’ll be presenting new findings on laser-supported detoxification and immune recovery. If you're attending, let’s connect in person.

---

Final Thought

Light therapy is not an alternative, it’s an addition. A complement to conventional care that reintroduces energy where it’s been lost, and trust where medicine has often fallen short.

Thank you for being part of this movement toward transparent, accessible, and regenerative health.

Until next time, Robert

Source & credit: Weber Medical